Traitements4programmes
Essais2liés
Publications3liées
SourceDBlocale

Traitements

4
MoléculeIndication / populationPhaseObjectifPaysRésultat
Click Digital TherapeuticRandomized study of two digital therapeutics for the prevention of episodic migraine in patients currently receiving Calcitonin Gene-Related Peptide (CGRP) Inhibitor Therapy Migraine Phase 3 À vérifier United States À vérifier
ReMMi-D Digital TherapeuticRandomized study of two digital therapeutics for the prevention of episodic migraine Migraine Non applicable À vérifier United States À vérifier
Click Digital TherapeuticRandomized study of two digital therapeutics for the prevention of episodic migraine in patients currently receiving Calcitonin Gene-Related Peptide (CGRP) Inhibitor Therapy Migraine Phase 3 À vérifier United States À vérifier
ReMMi-D Digital TherapeuticRandomized study of two digital therapeutics for the prevention of episodic migraine Migraine Non applicable À vérifier United States À vérifier

Essais cliniques

2
MoléculeIndication / populationPhaseNCTTitreStatut
ReMMi-D Digital Therapeutic Migraine Non applicable NCT05853900 ReMMi-D — Study of Two Digital Therapeutics for the Prevention of Episodic Migraine COMPLETED
Click Digital Therapeutic Migraine Phase 3 NCT06004388 Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) COMPLETED

Publications

3
MoléculeIndication / populationTitreJournalDate
Click Digital Therapeutic Digital therapeutics for negative symptoms of psychosis: Where do we go from here? Schizophrenia research
Click Digital Therapeutic Short dextran-solanesol block copolymer as a bio-based platform for multifunctional wormlike micelles. Carbohydrate polymers
Click Digital Therapeutic Digital Remote Assessment of Motor and Speech Changes in Amyotrophic Lateral Sclerosis: Longitudinal Observational Study. JMIR formative research